Connect your AI

Scilex Holding Company SCLX Current Debt

Current Debt at other companies

ViatrisVTRS

$1.93B+22,619%

Rigel PharmaceuticalsRIGL

$22.5M—

Opko HealthOPK

$1.53M+7.2%

Bristol-Myers SquibbBMY

$2.31B-35.1%

Other financials

Income statement

Revenue$8.6M+72.1%

Gross profit$4.2M+15.1%

Operating income-$32.2M-15.3%

Net income-$45.7M-75.0%

EPS (diluted)-$6.28-178%

Balance sheet

Cash & equivalents$3.4M-42.2%

Total debt$95.4M+130%

Total equity-$249.2M-17.8%

Total assets$293.6M+272%

Cash flow

Operating cash flow-$1.1M-118%

CapEx$33.3K—

Free cash flow$920.8K-63.7%

Valuation

Market cap$54.86M+88.7%

Enterprise value$146.86M+120%

P/S1.6×+1.0×

Profitability

Gross margin59.7%-12.3pp

Operating margin-1,034.4%-1,313pp

Net margin-1,162.4%-1,359pp

FCF margin12.2%—

Returns & leverage

Return on equity170.9%—

Debt / equity0.3×—

Current ratio0.1×0.0×

Where this comes from

Reported directly by Scilex Holding Company in its filing.

Tagged under the XBRL concept us-gaap:DebtCurrent.

The official record: Scilex Holding Company’s 10-Q, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scilex Holding Company's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Scilex Holding Company's current debt?: Scilex Holding Company (SCLX) reported current debt of $80.78M in Q1 2026.
How has Scilex Holding Company's current debt changed year-over-year?: Scilex Holding Company's current debt increased by 104.8% year-over-year, from $39.44M to $80.78M.
What is the long-term trend for Scilex Holding Company's current debt?: Over 4 years (2021 to 2025), Scilex Holding Company's current debt has grown at a 21.7% compound annual growth rate (CAGR), from $37.95M to $83.26M.
What does current debt mean?: The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.